Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(20 Publications)
Rabbit Recombinant Monoclonal Nuclear Matrix Protein p84 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 20 publications.
View Alternative Names
HPR1, THOC1, THO complex subunit 1, Nuclear matrix protein p84, hTREX84, p84N5
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)] (AB131268)
Immunohistochemical analysis of paraffin embedded human breast carcinoma tissue labeling Nuclear Matrix Protein p84 with ab131268 at 1/50 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)] (AB131268)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling Nuclear Matrix Protein p84 with purified ab131268 at 1/120 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)] (AB131268)
Immunofluorescent staining of HeLa cells labelling Nuclear Matrix Protein p84 with ab131268 at 1/100 dilution.
- WB
Unknown
Western blot - Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)] (AB131268)
All lanes:
Western blot - Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)] (ab131268) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
U-87 MG cell lysate at 10 µg
Lane 3:
293T cell lysate at 10 µg
Lane 4:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 76 kDa
false
Related conjugates and formulations (1)
-
Anti-Nuclear Matrix Protein p84 antibody [EPR5662(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nuclear Matrix Protein p84 assists in nuclear architecture maintenance and organization. It takes part in DNA replication processes and gene regulation by interacting with chromatin and transcription factors. Furthermore p84 contributes to the formation of the ribonucleoprotein complex facilitating RNA processing and transport. This involvement in multiple nuclear tasks positions it as a critical player in gene expression regulation mechanisms.
Pathways
Nuclear Matrix Protein p84 influences vital cellular activities such as the cell cycle and DNA repair. Its connections are apparent in the regulation of the p53 signaling pathway where it interacts with several regulatory proteins to monitor cell cycle progression and stress responses. p84’s activity also aligns with the DNA damage response pathway highlighting its cooperation with checkpoint proteins like ATM and ATR that uphold genomic integrity during cellular stress conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Regenerative biomaterials 12:rbaf090 PubMed40979828
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 18:eado8860 PubMed39772531
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 14:2520-2536 PubMed38828143
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37046850
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular systems biology 19:e11294 PubMed36929731
2023
Applications
Unspecified application
Species
Unspecified reactive species
Endocrine-related cancer 30: PubMed36606578
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:940926 PubMed36185280
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:14923 PubMed36056157
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 21:444 PubMed34419066
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:776 PubMed34055075
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com